Published in Anal Chem on August 15, 2005
Self-assembly of phenylalanine oligopeptides: insights from experiments and simulations. Biophys J (2009) 0.92
Designing a nanotube using naturally occurring protein building blocks. PLoS Comput Biol (2006) 0.91
Nanomaterials: amyloids reflect their brighter side. Nano Rev (2011) 0.86
Modification of hydrophilic and hydrophobic surfaces using an ionic-complementary peptide. PLoS One (2007) 0.86
Ultrasmall peptides self-assemble into diverse nanostructures: morphological evaluation and potential implications. Int J Mol Sci (2011) 0.81
Tuning the mechanical properties of self-assembled mixed-peptide tubes. J Microsc (2013) 0.77
Ubiquitous amyloids. Appl Biochem Biotechnol (2012) 0.76
Fibril-mediated oligomerization of pilin-derived protein nanotubes. J Nanobiotechnology (2013) 0.76
Bioinspired nanoscale materials for biomedical and energy applications. J R Soc Interface (2014) 0.76
Chemically and thermally stable silica nanowires with a β-sheet peptide core for bionanotechnology. J Nanobiotechnology (2016) 0.76
Polarized Raman Spectroscopy for Determining the Orientation of di-D-phenylalanine Molecules in a Nanotube. J Raman Spectrosc (2016) 0.75
Enzymatically Regulated Peptide Pairing and Catalysis for the Bioanalysis of Extracellular Prometastatic Activities of Functionally Linked Enzymes. Sci Rep (2016) 0.75
Synthetic methodology for asymmetric ferrocene derived bio-conjugate systems via solid phase resin-based methodology. J Vis Exp (2015) 0.75
"Janus" Calixarenes: Double-Sided Molecular Linkers for Facile, Multianchor Point, Multifunctional, Surface Modification. Langmuir (2016) 0.75
Casting metal nanowires within discrete self-assembled peptide nanotubes. Science (2003) 3.59
Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism. Chem Biol Drug Des (2006) 3.04
Controlled patterning of aligned self-assembled peptide nanotubes. Nat Nanotechnol (2006) 2.14
Amyloids: not only pathological agents but also ordered nanomaterials. Angew Chem Int Ed Engl (2008) 1.66
Amyloid fibril formation by pentapeptide and tetrapeptide fragments of human calcitonin. J Biol Chem (2002) 1.66
Allostery and intrinsic disorder mediate transcription regulation by conditional cooperativity. Cell (2010) 1.65
Inhibition of islet amyloid polypeptide fibril formation: a potential role for heteroaromatic interactions. Biochemistry (2004) 1.60
The YefM antitoxin defines a family of natively unfolded proteins: implications as a novel antibacterial target. J Biol Chem (2003) 1.56
Energy landscape of amyloidogenic peptide oligomerization by parallel-tempering molecular dynamics simulation: significant role of Asn ladder. Proc Natl Acad Sci U S A (2005) 1.43
Peptide-based hydrogel nanoparticles as effective drug delivery agents. Bioorg Med Chem (2013) 1.42
Self-assembled peptide nanotubes are uniquely rigid bioinspired supramolecular structures. Nano Lett (2005) 1.38
The human islet amyloid polypeptide forms transient membrane-active prefibrillar assemblies. Biochemistry (2003) 1.30
Low-cost printing of poly(dimethylsiloxane) barriers to define microchannels in paper. Anal Chem (2008) 1.30
Strong piezoelectricity in bioinspired peptide nanotubes. ACS Nano (2010) 1.25
In vivo aggregation of a single enzyme limits growth of Escherichia coli at elevated temperatures. Mol Microbiol (2002) 1.22
Novel electrochemical biosensing platform using self-assembled peptide nanotubes. Nano Lett (2005) 1.22
Identification and characterization of a novel molecular-recognition and self-assembly domain within the islet amyloid polypeptide. J Mol Biol (2002) 1.21
Self-assembled arrays of peptide nanotubes by vapour deposition. Nat Nanotechnol (2009) 1.20
Molecular mapping of the recognition interface between the islet amyloid polypeptide and insulin. Angew Chem Int Ed Engl (2006) 1.17
The yefM-yoeB toxin-antitoxin systems of Escherichia coli and Streptococcus pneumoniae: functional and structural correlation. J Bacteriol (2006) 1.12
Inhibition of amyloid fibril formation by peptide analogues modified with alpha-aminoisobutyric acid. Angew Chem Int Ed Engl (2004) 1.10
Elementary building blocks of self-assembled peptide nanotubes. J Am Chem Soc (2010) 1.06
Complete phenotypic recovery of an Alzheimer's disease model by a quinone-tryptophan hybrid aggregation inhibitor. PLoS One (2010) 1.06
Thermal and chemical stability of diphenylalanine peptide nanotubes: implications for nanotechnological applications. Langmuir (2006) 1.06
Peptide sequence and amyloid formation; molecular simulations and experimental study of a human islet amyloid polypeptide fragment and its analogs. Structure (2004) 1.05
Phenylalanine assembly into toxic fibrils suggests amyloid etiology in phenylketonuria. Nat Chem Biol (2012) 1.05
Green tea extracts interfere with the stress-protective activity of PrP and the formation of PrP. J Neurochem (2008) 1.04
Structural and thermodynamic characterization of the Escherichia coli RelBE toxin-antitoxin system: indication for a functional role of differential stability. Biochemistry (2007) 1.04
Cognitive-performance recovery of Alzheimer's disease model mice by modulation of early soluble amyloidal assemblies. Angew Chem Int Ed Engl (2009) 1.03
Fabrication of coaxial metal nanocables using a self-assembled peptide nanotube scaffold. Nano Lett (2006) 1.02
The physical properties of supramolecular peptide assemblies: from building block association to technological applications. Chem Soc Rev (2014) 1.01
Inhibition of amyloid fibril formation and cytotoxicity by hydroxyindole derivatives. Biochemistry (2006) 1.01
Orally administrated cinnamon extract reduces β-amyloid oligomerization and corrects cognitive impairment in Alzheimer's disease animal models. PLoS One (2011) 1.01
The formation of Escherichia coli curli amyloid fibrils is mediated by prion-like peptide repeats. J Mol Biol (2005) 1.00
Blue luminescence based on quantum confinement at peptide nanotubes. Nano Lett (2009) 0.96
Peptide self-assembly at the nanoscale: a challenging target for computational and experimental biotechnology. Trends Biotechnol (2007) 0.95
Designed aromatic homo-dipeptides: formation of ordered nanostructures and potential nanotechnological applications. Phys Biol (2006) 0.95
The von Hippel-Lindau tumor suppressor protein is a molten globule under native conditions: implications for its physiological activities. J Biol Chem (2004) 0.94
Inhibiting α-synuclein oligomerization by stable cell-penetrating β-synuclein fragments recovers phenotype of Parkinson's disease model flies. PLoS One (2010) 0.93
Self-assembly of phenylalanine oligopeptides: insights from experiments and simulations. Biophys J (2009) 0.92
The minimal amyloid-forming fragment of the islet amyloid polypeptide is a glycolipid-binding domain. FEBS J (2006) 0.91
Expanding the solvent chemical space for self-assembly of dipeptide nanostructures. ACS Nano (2014) 0.91
Quantum confinement in self-assembled bioinspired peptide hydrogels. Adv Mater (2010) 0.91
Carbon nanotubes based electrochemical biosensor for detection of formaldehyde released from a cancer cell line treated with formaldehyde-releasing anticancer prodrugs. Bioelectrochemistry (2009) 0.91
Amyloidogenic hexapeptide fragment of medin: homology to functional islet amyloid polypeptide fragments. Amyloid (2004) 0.90
Controlled patterning of peptide nanotubes and nanospheres using inkjet printing technology. J Pept Sci (2008) 0.90
Molecular dynamics simulation of the aggregation of the core-recognition motif of the islet amyloid polypeptide in explicit water. Proteins (2005) 0.90
Vertically aligned peptide nanostructures using plasma-enhanced chemical vapor deposition. Biomacromolecules (2014) 0.89
Design of metal-binding sites onto self-assembled peptide fibrils. Biopolymers (2009) 0.88
A model for the role of short self-assembled peptides in the very early stages of the origin of life. FASEB J (2005) 0.88
Polyphenol-induced dissociation of various amyloid fibrils results in a methionine-independent formation of ROS. Biochim Biophys Acta (2008) 0.87
Self-assembled Fmoc-peptides as a platform for the formation of nanostructures and hydrogels. Biomacromolecules (2009) 0.86
Self-assembled organic nanostructures with metallic-like stiffness. Angew Chem Int Ed Engl (2010) 0.86
Characterization of peptide-nanostructure-modified electrodes and their application for ultrasensitive environmental monitoring. Small (2010) 0.85
Phenolsulfonphthalein, but not phenolphthalein, inhibits amyloid fibril formation: implications for the modulation of amyloid self-assembly. Biochemistry (2008) 0.85
The structural basis of amyloid formation. Curr Alzheimer Res (2008) 0.85
Completely different amyloidogenic potential of nearly identical peptide fragments. Biopolymers (2003) 0.85
Genetic engineering of biomolecular scaffolds for the fabrication of organic and metallic nanowires. Angew Chem Int Ed Engl (2010) 0.85
Direct observation of the release of phenylalanine from diphenylalanine nanotubes. J Am Chem Soc (2006) 0.84
Crystallization of Doc and the Phd-Doc toxin-antitoxin complex. Acta Crystallogr Sect F Struct Biol Cryst Commun (2008) 0.83
The YoeB toxin is a folded protein that forms a physical complex with the unfolded YefM antitoxin. Implications for a structural-based differential stability of toxin-antitoxin systems. J Biol Chem (2005) 0.83
The molecular mechanisms of the anti-amyloid effects of phenols. Amyloid (2007) 0.83
Detecting endocrine-disrupting compounds by fast impedance measurements. Environ Sci Technol (2002) 0.82
Bioinspired design of nanocages by self-assembling triskelion peptide elements. Angew Chem Int Ed Engl (2007) 0.82
The preferred conformation of the tripeptide Ala-Phe-Ala in water is an inverse gamma-turn: implications for protein folding and drug design. Biochemistry (2005) 0.82
Differential inhibition of α-synuclein oligomeric and fibrillar assembly in parkinson's disease model by cinnamon extract. Biochim Biophys Acta (2012) 0.82
Biological and chemical decoration of peptide nanostructures via biotin-avidin interactions. J Nanosci Nanotechnol (2007) 0.82
Amperometric quantification of total coliforms and specific detection of Escherichia coli. Anal Chem (2002) 0.82
Evaluating Drosophila p53 as a model system for studying cancer mutations. J Biol Chem (2012) 0.82
Converting the highly amyloidogenic human calcitonin into a powerful fibril inhibitor by three-dimensional structure homology with a non-amyloidogenic analogue. J Biol Chem (2010) 0.82
Why are diphenylalanine-based peptide nanostructures so rigid? Insights from first principles calculations. J Am Chem Soc (2014) 0.81
The role of Bacillus thuringiensis Cry1C and Cry1E separate structural domains in the interaction with Spodoptera littoralis gut epithelial cells. J Biol Chem (2004) 0.81
The role of the 14-20 domain of the islet amyloid polypeptide in amyloid formation. Exp Diabetes Res (2008) 0.81
Targeting insulin amyloid assembly by small aromatic molecules: toward rational design of aggregation inhibitors. Islets (2010) 0.81
The early stages of amyloid formation: biophysical and structural characterization of human calcitonin pre-fibrillar assemblies. Amyloid (2006) 0.80
Controlled assembly of peptide nanotubes triggered by enzymatic activation of self-immolative dendrimers. Chembiochem (2007) 0.79
Seamless metallic coating and surface adhesion of self-assembled bioinspired nanostructures based on di-(3,4-dihydroxy-L-phenylalanine) peptide motif. ACS Nano (2014) 0.79
A blood-brain barrier (BBB) disrupter is also a potent α-synuclein (α-syn) aggregation inhibitor: a novel dual mechanism of mannitol for the treatment of Parkinson disease (PD). J Biol Chem (2013) 0.79
Coassembly of aromatic dipeptides into biomolecular necklaces. ACS Nano (2012) 0.79
Genetically engineered pfabA pfabR bacteria: an electrochemical whole cell biosensor for detection of water toxicity. Anal Chem (2006) 0.79
Novel integrated electrochemical nano-biochip for toxicity detection in water. Nano Lett (2005) 0.79
Mechanically functional amyloid fibrils in the adhesive of a marine invertebrate as revealed by Raman spectroscopy and atomic force microscopy. Arch Histol Cytol (2009) 0.79
Formation of low-dimensional crystalline nucleus region during insulin amyloidogenesis process. Biochem Biophys Res Commun (2012) 0.79
Analog modeling of Worm-Like Chain molecules using macroscopic beads-on-a-string. Phys Chem Chem Phys (2012) 0.79
The generic amyloid formation inhibition effect of a designed small aromatic β-breaking peptide. Amyloid (2011) 0.78
Phase separation of 2D meso-scale Coulombic crystals from meso-scale polarizable "solvent" Soft Matter (2009) 0.78
Controlling molecular self-assembly: from amyloid oligomerization and therapy to novel biomaterials and technological applications in nanomedicine. Nanomedicine (Lond) (2014) 0.78
Probing the interaction of individual amino acids with inorganic surfaces using atomic force spectroscopy. Langmuir (2013) 0.78
Self-assembling peptide and protein amyloids: from structure to tailored function in nanotechnology. Chem Soc Rev (2017) 0.78
Is Nitric Oxide Assuming a Janus-Face in The Central Nervous System? Curr Med Chem (2016) 0.78